Anna Coleman

1.9k total citations
128 papers, 1.3k citations indexed

About

Anna Coleman is a scholar working on General Health Professions, Education and Economics and Econometrics. According to data from OpenAlex, Anna Coleman has authored 128 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in General Health Professions, 48 papers in Education and 18 papers in Economics and Econometrics. Recurrent topics in Anna Coleman's work include Primary Care and Health Outcomes (51 papers), Healthcare innovation and challenges (47 papers) and Interprofessional Education and Collaboration (22 papers). Anna Coleman is often cited by papers focused on Primary Care and Health Outcomes (51 papers), Healthcare innovation and challenges (47 papers) and Interprofessional Education and Collaboration (22 papers). Anna Coleman collaborates with scholars based in United Kingdom, United States and Qatar. Anna Coleman's co-authors include Kath Checkland, Imelda McDermott, Stephen Harrison, Kirstein Rummery, Pauline Allen, Stephen Peckham, Julia Segar, Caroline Glendinning, David Wilkin and Ruth McDonald and has published in prestigious journals such as Social Science & Medicine, BMJ and Frontiers in Psychology.

In The Last Decade

Anna Coleman

116 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Coleman United Kingdom 21 970 382 279 127 124 128 1.3k
Viola Burau Denmark 20 568 0.6× 152 0.4× 228 0.8× 124 1.0× 92 0.7× 83 1.0k
Susan Pickard United Kingdom 24 870 0.9× 220 0.6× 246 0.9× 121 1.0× 155 1.3× 69 1.5k
Hester van de Bovenkamp Netherlands 20 780 0.8× 119 0.3× 282 1.0× 125 1.0× 111 0.9× 80 1.3k
Rod Sheaff United Kingdom 22 1.0k 1.1× 205 0.5× 349 1.3× 195 1.5× 240 1.9× 99 1.5k
Stephen Harrison United Kingdom 20 674 0.7× 124 0.3× 299 1.1× 187 1.5× 286 2.3× 33 1.1k
Rob Baggott United Kingdom 18 500 0.5× 157 0.4× 137 0.5× 141 1.1× 35 0.3× 48 964
Catherine Warwick United Kingdom 7 634 0.7× 146 0.4× 164 0.6× 90 0.7× 173 1.4× 12 1.1k
Damien Contandriopoulos Canada 18 805 0.8× 73 0.2× 232 0.8× 138 1.1× 59 0.5× 69 1.3k
Chris Ham United Kingdom 19 940 1.0× 160 0.4× 517 1.9× 146 1.1× 284 2.3× 80 1.5k
Ellen Kuhlmann Germany 24 764 0.8× 83 0.2× 293 1.1× 187 1.5× 145 1.2× 112 1.6k

Countries citing papers authored by Anna Coleman

Since Specialization
Citations

This map shows the geographic impact of Anna Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Coleman more than expected).

Fields of papers citing papers by Anna Coleman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Coleman. The network helps show where Anna Coleman may publish in the future.

Co-authorship network of co-authors of Anna Coleman

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Coleman. A scholar is included among the top collaborators of Anna Coleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Coleman. Anna Coleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hua, Wei, et al.. (2025). Return to work with long COVID: a rapid review of support and challenges. BMJ Open. 15(10). e101698–e101698. 1 indexed citations
2.
Langley, Richard G., Anna Coleman, Marius Ardeleanu, et al.. (2025). The Safety Data of Dupilumab for the Treatment of Moderate‑to‑Severe Atopic Dermatitis in Infants, Children, Adolescents, and Adults. American Journal of Clinical Dermatology. 26(6). 981–1002.
3.
Coleman, Anna, Nicola Gartland, Sheena Johnson, David Fishwick, & Martie van Tongeren. (2024). Public transport in the UK: Considerations for continued rehabilitation and future planning for a sector impacted by COVID-19. Transportation Research Interdisciplinary Perspectives. 24. 101044–101044. 2 indexed citations
5.
Siegfried, Elaine C., Lara Wine Lee, Jonathan M. Spergel, et al.. (2024). A case series of live attenuated vaccine administration in dupilumab‐treated children with atopic dermatitis. Pediatric Dermatology. 41(2). 204–209. 9 indexed citations
6.
Beck, Lisa A., Robert Bissonnette, Mette Deleuran, et al.. (2024). Dupilumab in Adults With Moderate to Severe Atopic Dermatitis. JAMA Dermatology. 160(8). 805–805. 30 indexed citations
7.
Paller, Amy S., Michele Ramien, Michael J. Cork, et al.. (2024). Low Infection Rates With Long‐Term Dupilumab Treatment in Patients Aged 6 Months to 5 Years: An Open‐Label Extension Study. Pediatric Dermatology. 42(2). 251–258.
8.
Armitage, Christopher J., Chris Keyworth, Nicola Gartland, et al.. (2023). Theory-based Trial to Promote Uptake and Sustained Use of Face Coverings During the COVID-19 Pandemic. Annals of Behavioral Medicine. 57(11). 921–928.
9.
Gartland, Nicola, David Fishwick, Anna Coleman, et al.. (2022). Transmission and control of SARS-CoV-2 on ground public transport: A rapid review of the literature up to May 2021. Journal of Transport & Health. 26. 101356–101356. 17 indexed citations
10.
Checkland, Kath, et al.. (2021). National Evaluation of the Vanguard New Care Models Programme Report of qualitative case studies: understanding system change. Kent Academic Repository (University of Kent). 4 indexed citations
11.
Morciano, Marcello, Kath Checkland, Jenny R. Billings, et al.. (2020). New integrated care models in England associated with small reduction in hospital admissions in longer-term: A difference-in-differences analysis. Health Policy. 124(8). 826–833. 46 indexed citations
12.
Checkland, Kath, et al.. (2019). National evaluation of the Vanguard new care models programme interim report: understanding the national support programme. Kent Academic Repository (University of Kent). 11 indexed citations
13.
Hammond, Jonathan, Thomas Mason, Matt Sutton, et al.. (2019). Exploring the impacts of the 2012 Health and Social Care Act reforms to commissioning on clinical activity in the English NHS: a mixed methods study of cervical screening. BMJ Open. 9(4). e024156–e024156. 2 indexed citations
14.
Hammond, Jonathan, Ewen Speed, Pauline Allen, et al.. (2018). Autonomy, accountability, and ambiguity in arm’s-length meta-governance: the case of NHS England. Public Management Review. 21(8). 1148–1169. 28 indexed citations
16.
17.
Moran, Valérie, Kath Checkland, Anna Coleman, et al.. (2017). General practitioners’ views of clinically led commissioning: cross-sectional survey in England. BMJ Open. 7(6). e015464–e015464. 5 indexed citations
18.
McDermott, Imelda, et al.. (2016). Understanding primary care co-commissioning:Uptake, scope of activity and process of change. Research Explorer (The University of Manchester). 4 indexed citations
19.
Petsoulas, Christina, Pauline Allen, Kath Checkland, et al.. (2014). Views of NHS commissioners on commissioning support provision. Evidence from a qualitative study examining the early development of clinical commissioning groups in England. BMJ Open. 4(10). e005970–e005970. 21 indexed citations
20.
Checkland, Kath, Pauline Allen, Anna Coleman, et al.. (2013). Accountable to whom, for what? An exploration of the early development of Clinical Commissioning Groups in the English NHS. BMJ Open. 3(12). e003769–e003769. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026